Medicare’s Price Negotiation: What’s Off the Table

The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate Medicare drug prices with manufacturers.